Peripheral immune and inflammatory markers as predictors of neoadjuvant immunotherapy response in head and neck squamous cell carcinoma
Background Head and neck squamous cell carcinoma (HNSCC) is a common and challenging malignancy, with limited response rates to immune checkpoint inhibitors (ICIs). Accurate blood-based biomarkers are needed to predict immunotherapy responses, aiding patient stratification in neoadjuvant settings.Ma...
Saved in:
| Main Authors: | Wendi Li, Lin Xiao, Haiyang Li, Dan Zuo, Kai Guo, Ye Zhang, Wei Cui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2522322 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in neoantigen-based immunotherapy for head and neck squamous cell carcinoma: a comprehensive review
by: Manzhu Jiang, et al.
Published: (2025-05-01) -
Pathological regression patterns following neoadjuvant chemo-immunotherapy in head and neck squamous cell carcinoma: a pilot study
by: Dikan Wang, et al.
Published: (2025-08-01) -
Neoadjuvant Immunotherapy in Head and Neck Cancers: A Paradigm Shift in Treatment Approach
by: Alessia Zotta, et al.
Published: (2024-10-01) -
Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma
by: Bryce Hambach, et al.
Published: (2025-07-01) -
Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
by: Sandra Llop, et al.
Published: (2024-11-01)